
-
2000
Company Description
InDex Pharmaceuticals is a biopharmaceutical company developing DIMS drugs to treat inflammatory diseases and cancer.
InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.
-
Manufacturer:
Science and Engineering -
Formed:
2000 -
Company Website:
-
Company E-mail:
-
Company Address:
Scheeles väg 2StockholmSweden -
CEO:
- Jesper Wiklund
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits